Breast Cancer Immunotherapy: Facts and Hopes von Emens, Leisha A

Volltext

The interplay of immunotherapy and chemotherapy: harnessing potential synergies von Emens, Leisha A, Middleton, Gary

Volltext

Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape von Emens, Leisha A, Ascierto, Paolo A, Darcy, Phillip K, Demaria, Sandra, Eggermont, Alexander M.M, Redmond, William L, Seliger, Barbara, Marincola, Francesco M

Volltext

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study von Emens, Leisha A, Molinero, Luciana, Loi, Sherene, Rugo, Hope S, Schneeweiss, Andreas, Diéras, Véronique, Iwata, Hiroji, Barrios, Carlos H, Nechaeva, Marina, Nguyen-Duc, Anh, Chui, Stephen Y, Husain, Amreen, Winer, Eric P, Adams, Sylvia, Schmid, Peter

Volltext

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas von Cimino-Mathews, Ashley, MD, Thompson, Elizabeth, MD, PhD, Taube, Janis M., MD, Ye, Xiaobu, MD, Lu, Yao, MS, Meeker, Alan, PhD, Xu, Haiying, BS, Sharma, Rajni, PhD, Lecksell, Kristen, MS, Cornish, Toby C., MD, PhD, Cuka, Nathan, MD, Argani, Pedram, MD, Emens, Leisha A., MD

Volltext

Antagonists of PD-1 and PD-L1 in Cancer Treatment von Lipson, Evan J, Forde, Patrick M, Hammers, Hans-Joerg, Emens, Leisha A, Taube, Janis M, Topalian, Suzanne L

Volltext

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer von Fong, Lawrence, Hotson, Andrew, Powderly, John D., Sznol, Mario, Heist, Rebecca S., Choueiri, Toni K., George, Saby, Hughes, Brett G. M., Hellmann, Matthew D., Shepard, Dale R., Rini, Brian I., Kummar, Shivaani, Weise, Amy M., Riese, Matthew J., Markman, Ben, Emens, Leisha A., Mahadevan, Daruka, Luke, Jason J., Laport, Ginna, Brody, Joshua D., Hernandez-Aya, Leonel, Bonomi, Philip, Goldman, Jonathan W., Berim, Lyudmyla, Renouf, Daniel J., Goodwin, Rachel A., Munneke, Brian, Ho, Po Y., Hsieh, Jessica, McCaffery, Ian, Kwei, Long, Willingham, Stephen B., Miller, Richard A.

Volltext

Targeting adenosine for cancer immunotherapy von Leone, Robert D, Emens, Leisha A

Volltext

Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide von Lesniak, Wojciech G., Mease, Ronnie C., Chatterjee, Samit, Kumar, Dhiraj, Lisok, Ala, Wharram, Bryan, Kalagadda, Venkateswara Rao, Emens, Leisha A., Pomper, Martin G., Nimmagadda, Sridhar

Volltext

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study von Cimino-Mathews, Ashley, MD, Ye, Xiaobu, MS, MD, Meeker, Alan, PhD, Argani, Pedram, MD, Emens, Leisha A., MD, PhD

Volltext

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer von Mi, Haoyang, Gong, Chang, Sulam, Jeremias, Fertig, Elana J., Szalay, Alexander S., Jaffee, Elizabeth M., Stearns, Vered, Emens, Leisha A., Cimino-Mathews, Ashley M., Popel, Aleksander S.

Volltext

Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dos... von Emens, Leisha A, Asquith, Justin M, Leatherman, James M, Kobrin, Barry J, Petrik, Silvia, Laiko, Marina, Levi, Joy, Daphtary, Maithili M, Biedrzycki, Barbara, Wolff, Antonio C, Stearns, Vered, Disis, Mary L, Ye, Xiaobu, Piantadosi, Steven, Fetting, John H, Davidson, Nancy E, Jaffee, Elizabeth M

Volltext

Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer von Wang, Hanwen, Zhao, Chen, Santa-Maria, Cesar A., Emens, Leisha A., Popel, Aleksander S.

Volltext

Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer von Wang, Hanwen, Ma, Huilin, Sové, Richard J, Emens, Leisha A, Popel, Aleksander S

Volltext

Predictive Biomarkers: Progress on the Road to Personalized Cancer Immunotherapy von Emens, Leisha A.

Volltext

Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis von Petrelli, Fausto, Bertaglia, Valentina, Parati, Maria Chiara, Borgonovo, Karen, De Silva, Pushpamali, Luciani, Andrea, Novello, Silvia, Scartozzi, Mario, Emens, Leisha A., Solinas, Cinzia

Volltext

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer von Emens, Leisha A, Adams, Sylvia, Cimino-Mathews, Ashley, Disis, Mary L, Gatti-Mays, Margaret E, Ho, Alice Y, Kalinsky, Kevin, McArthur, Heather L, Mittendorf, Elizabeth A, Nanda, Rita, Page, David B, Rugo, Hope S, Rubin, Krista M, Soliman, Hatem, Spears, Patricia A, Tolaney, Sara M, Litton, Jennifer K

Volltext

Advances and challenges in cancer immunoprevention and immune interception von Stanton, Sasha E, Castle, Philip E, Finn, Olivera J, Sei, Shizuko, Emens, Leisha A

Volltext

Chemoimmunotherapy: reengineering tumor immunity von Chen, Gang, Emens, Leisha A.

Volltext

Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors von Zhu, Li, Narloch, Jessica L., Onkar, Sayali, Joy, Marion, Broadwater, Gloria, Luedke, Catherine, Hall, Allison, Kim, Rim, Pogue-Geile, Katherine, Sammons, Sarah, Nayyar, Naema, Chukwueke, Ugonma, Brastianos, Priscilla K., Anders, Carey K., Soloff, Adam C., Vignali, Dario A. A., Tseng, George C., Emens, Leisha A., Lucas, Peter C., Blackwell, Kimberly L., Oesterreich, Steffi, Lee, Adrian V.

Volltext